E
Emanuele Voulaz
Researcher at Humanitas University
Publications - 57
Citations - 1521
Emanuele Voulaz is an academic researcher from Humanitas University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 14, co-authored 44 publications receiving 1125 citations.
Papers
More filters
Journal ArticleDOI
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.
Maurizio Infante,Silvio Cavuto,Fabio Romano Lutman,Giorgio Brambilla,G Chiesa,Giovanni Luca Ceresoli,Eliseo Passera,Enzo Angeli,Maurizio Chiarenza,Giuseppe Aranzulla,Umberto Cariboni,Valentina Errico,Francesco Inzirillo,Edoardo Bottoni,Emanuele Voulaz,Marco Alloisio,Anna Destro,Massimo Roncalli,Armando Santoro,Gianluigi Ravasi +19 more
TL;DR: In this paper, the authors explored the effect of screening with low-dose spiral computed tomography (LDCT) on lung cancer mortality and found that the mortality benefit from lung cancer screening by LDCT might be far smaller than anticipated.
Journal ArticleDOI
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
Maurizio Infante,Silvio Cavuto,Fabio Romano Lutman,Eliseo Passera,Maurizio Chiarenza,G Chiesa,Giorgio Brambilla,Enzo Angeli,Giuseppe Aranzulla,Arturo Chiti,Marta Scorsetti,Pierina Navarria,Raffaele Cavina,Michele Ciccarelli,Massimo Roncalli,Anna Destro,Edoardo Bottoni,Emanuele Voulaz,Valentina Errico,Giorgio Maria Ferraroli,Giovanna Finocchiaro,Luca Toschi,Armando Santoro,Marco Alloisio +23 more
TL;DR: The results of the DANTE (Detection and screening of early lung cancer with Novel imaging TEchnology) trial do not allow us to make a definitive statement about the efficacy of LDCT screening, but underline the importance of obtaining additional data from randomized trials with intervention-free reference arms before the implementation of population screening.
Journal ArticleDOI
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery
Margarita Kirienko,Luca Cozzi,Lidija Antunovic,Lisa Lozza,Antonella Fogliata,Emanuele Voulaz,Alexia Rossi,Arturo Chiti,Martina Sollini +8 more
TL;DR: A radiomic signature, for either CT, PET, or PET/CT images, has been identified and validated for the prediction of disease-free survival in patients with non-small cell lung cancer treated by surgery.
Journal ArticleDOI
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions
Margarita Kirienko,Luca Cozzi,Alexia Rossi,Emanuele Voulaz,Lidija Antunovic,Antonella Fogliata,Arturo Chiti,Martina Sollini +7 more
TL;DR: PET radiomics features were able to differentiate between primary and metastatic lung lesions and showed the potential to identify primary lung cancer subtypes.
Journal ArticleDOI
Robot-assisted surgery for lung cancer: State of the art and perspectives
TL;DR: The characteristics and function of the robotic system available today (namely, Intuitive Surgical Inc.'s da Vinci Surgical System), the different techniques for major lung resection via RATS, compare RATS with video-assisted thoracoscopic surgery (VATS), and speculate on future developments are reviewed.